Stockwinners Market Radar for March 10, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:46 EST Lyft CFO sells 20K shares of common stock - In a regulatory filing, Lyft disclosed that its CFO Brian Roberts sold 20K shares of common stock on March 8th in a total transaction size of $1.3M, reducing his stake by 2%.

19:35 EST SPDR Gold Shares holdings fall to 1,060.23MT from 1,061.98MT - This is the 6th consecutive decrease in holdings and the lowest level since April 30th, 2020.

18:25 EST Biohaven says over 50% of participants enrolled in verdiperstat regimen - Biohaven Pharmaceutical announced that more than 50% of participants have been enrolled in the verdiperstat regimen of HEALEY ALS Platform Trial, which is evaluating the efficacy of several treatments including verdiperstat in people with amyotrophic lateral sclerosis. Verdiperstat is a potential first-in-class, brain-penetrant, selective inhibitor of myeloperoxidase in development by Biohaven for the treatment of neurodegenerative diseases, including ALS and multiple system atrophy. Irfan Qureshi, MD, Biohaven Vice President and Verdiperstat Development Lead, stated, "We are pleased that enrollment in the trial is progressing rapidly and very grateful to our collaborators at the Healey Center and the ALS research community for their leadership, boundless enthusiasm, and perseverance. We are also deeply thankful to people with ALS and their families for their commitment to the HEALEY ALS Platform Trial."

18:03 EST T-Mobile invests roughly $9.3B in FCC's C-Band auction - T-Mobile said it has invested just over $9.3B in the FCC's C-Band auction, selectively acquiring additional mid-band spectrum it will use to take its 5G network to the next level and continue delivering massive customer benefits unlocked by the merger with Sprint. "T-Mobile customers are the clear winners in this auction. Our already industry-leading 5G network enabled us to be highly selective and strategic, concentrating our wins in top markets nationwide," said Mike Sievert, CEO of T-Mobile. "As I predicted last fall, the other guys spent an unbelievable amount - because they had to. And even then, the truth is that C-Band is best for urban areas because it doesn't propagate as well as T-Mobile's substantial existing mid-band frequencies. For us, C-Band makes a great story even better, and we are incredibly pleased with our clear success in this auction. Our competitors had no choice but to go all in with a break-the-bank attempt to remain relevant in the 5G era."

17:47 EST Crown Castle CFO Schlanger sells over $750K in shares - Crown Castle CFO Daniel Schlanger disclosed in a filing that he had sold 5,000 shares of company stock at $150.73 per share on March 9, for a total transaction amount of $753,640.

17:45 EST Talos Energy reports Q4 production 59.4K MBOE/D - CEO Timothy Duncan commented: "I am proud of how the Talos team responded to the challenges we all faced in 2020. With the onset of unexpected crises, our focus for the year was to further improve our cost structure and to bolster our asset value and credit profile through the capital plan, while also placing the business on solid footing to advance in 2021. After a challenging year, that is the position we are in. I'm particularly happy with our execution in the fourth quarter, with new wells coming online and continued success in our operating cost reduction efforts. That resulted in strong free cash flow generation in the quarter, as well as EBITDA margins going back over 60%, despite the hurricane downtime experienced in the quarter. By executing on different capital markets initiatives in late 2020 and early 2021, we have built a significant liquidity position and we are well-positioned moving forward. We also progressed in our emissions reduction initiatives in 2020, and we expect to report a third straight year of emissions reduction when our second annual ESG report is published by the summer of 2021. With improving margins and a continued focus on free cash flow generation, we expect to have a lower capital investment program in 2021 compared to 2020, despite an improving commodity price environment, balanced across low-risk projects and potential high-impact catalysts. We will take our successful platform rig program from our Green Canyon 18 facility to the Pompano area in Mississippi Canyon, and we will continue to invest in our successful Tornado water flood project. The Company also expects results from numerous high-impact catalysts in the coming months. Talos is presently participating in the high-impact Puma West exploration well. We are finalizing unitization and thereafter seeking to sanction our Zama project in Mexico, for which our third-party reserve auditor recently increased their resource estimates. Lastly, we're actively working on a diverse range of business development and M&A opportunities, building on our successful track record. Each of these opportunities could be material value drivers for our shareholders throughout the year and beyond."

17:35 EST Home Federal Bancorp declares two-for-one stock split as stock dividend - Home Federal Bancorp declared a two-for-one stock split in the form of a 100% stock dividend, payable March 31 to stockholders of record as of March 22. The company's stockholders will receive a dividend of one share for every share held on the record date. The dividend will be paid in authorized but unissued shares of common stock of the company. The par value of the company's stock will not be affected by the split and will remain at 1c per share. The company anticipates that the outstanding shares of stock after the split will be increased from approximately 1.7 million shares to 3.4 million shares. The company's most recent quarterly cash dividend was 16.5c per share payable on February 15. The board of directors anticipates maintaining a similar level of total cash dividends to shareholders post-split; thus, the quarterly cash dividend will be adjusted to be 8.25c per share.

17:22 EST Epic Games files legal proceedings against Google in Australia - "Epic Games announced that it has filed a legal claim against Google (GOOG, GOOGL) with the Federal Court of Australia, continuing its pursuit for fairer digital platforms globally. Epic has already filed a claim with the Court against Apple (AAPL) on similar grounds. In the claim Epic alleges that Google's anti-competitive conduct breaches the Australian Consumer Law as well as various sections of the Competition and Consumer Act 2010, Cth. The company states that Google abuses its control over the Android operating system ("Android OS"), restricting competition in payment processing and app distribution on the Google Play Store. This harmful conduct stifles innovation, reduces consumer choice and inflates prices. For apps obtained through the Google Play Store developers are forced to use Google's in-app payment services that take a 30% commission. Google also makes it egregiously difficult to download apps directly onto Android devices, forcing the vast majority of users to obtain apps through the Google Play Store. In fact, in Australia, almost half of the approximately 20 million smartphones across the country run on Google's Android OS, and 90% of apps on an Android mobile are typically obtained via the Google Play Store," said Epic Games in an earlier statement. Reference Link

17:04 EST Rambus, Mixel and Hardent collaborate on next-generation display solution - Mixel, Rambus and Hardent announced a solution for next-generation displays. This integrated solution brings together the IP of the three MIPI Alliance member companies enabling deployment of mobile, AR/VR and automotive displays leveraging MIPI DSI-2 technology. This solution is available immediately and includes: MIPI C-PHYSM/D-PHYSM Combo from Mixel, MIPI DSI-2 Controller from Rambus and VESA Display Stream Compression from Hardent. The companies said targeting display applications requiring high bandwidth and excellent power efficiency, this subsystem solution brings a significant improvement in overall throughput available with DSI-2.

17:01 EST Copa Holdings reports February traffic down 69.1%, capacity down 62.8% - Load factor was 69.6%, down 14.4 p.p.

16:56 EST Earthstone Energy reports Q4 average daily output 14.8K BOE/D vs 17.6K BOE/D y/y

16:41 EST Kadmon says FDA extends review for belumosudil NDA for cGVHD - Kadmon Holdings announced that the U.S. Food and Drug Administration has extended the review period for the New Drug Application for belumosudil for the treatment of chronic graft-versus-host disease. In a notice received from the FDA on March 9, the Company was informed that the Prescription Drug User Fee Act goal date for its Priority Review of belumosudil has been extended to August 30. The FDA extended the PDUFA date to allow time to review additional information submitted by Kadmon in response to a recent FDA information request. The submission of the additional information has been determined by the FDA to constitute a major amendment to the NDA, resulting in an extension of the PDUFA date by three months. "We remain confident in the data supporting our application for belumosudil in cGVHD and look forward to continuing to work closely with the FDA during the remainder of the review process," said Harlan W. Waksal, M.D., President and CEO of Kadmon. "We are committed to bringing belumosudil to market, once approved, to help meet the needs of patients living with cGVHD."

16:32 EST Victory Capital reports AUM $150.6B as of February 28th - Victory Capital reported assets under management of $150.6 billion on February 28, 2021 vs. $146.21B prior month-end.

16:26 EST Cloudera drops 10% to $13.25 after Q1, FY22 guidance misses estimates

16:22 EST AMC Entertainment jumps 2% to $10.05 after Q4 results, theater opening update

16:21 EST AMC CEO says confident actions taken will allow to capitalize on pent-up demand - CEO Adam Aron says: "During the fourth quarter, more than 8 million U.S. and international patrons confidently returned to an AMC theatre, assured of their safety due, in large part, to the robust steps we have taken through our AMC Safe & Clean protocols, designed in consultation with Clorox and current and former faculty of Harvard University's acclaimed School of Public Health, to ensure that we are reopening responsibly and with a focus on the health and safety of our guests and associates. The guest feedback we continue to receive is the highest we have seen for the cleanliness of our theatres, and I am grateful to our theatre crews for their focus and diligent efforts to successfully implement our safety protocols. Our most important single point of focus, after ensuring a safe and clean environment for our theatre guests and workforce, has been to strengthen AMC's liquidity profile. Since March of 2020, we have raised approximately $2.2 billion of gross cash proceeds from new debt and equity capital, securing more than $1 billion of concessions from creditors and landlords, raising more than $80 million from asset sales and seeing $600 million of convertible notes convert from debt to equity. I am confident that the actions that we have taken have positioned us well to capitalize on pent-up demand for movie going as the rollout of vaccines accelerates. We look forward to returning to an environment of unfettered movie theatre access for our guests, and we are eager to showcase the sizable and widely anticipated slate of new films that our studio partners have to offer."

16:19 EST AMC Entertainment operating 67% of domestic theaters as of Q4-end - The company states: "As of October 1, 2020, AMC had resumed operations at 467 of its domestic theatres, or approximately 78% of its domestic circuit, after having suspended operations for approximately five months beginning on March 17, 2020. During the fourth quarter ended December 31, 2020, in response to state and local government mandates related to a domestic resurgence of COVID-19, many of AMC's 467 reopened U.S. theatres suspended operations. As of December 31, 2020, AMC was operating at 394 domestic theatres with limited seating capacities of between 20% and 40%, representing approximately 67% of domestic theatres and 61% percent of 2019 domestic same-theatre revenue. Similarly, as of October 1, 2020, AMC had resumed operations at 321 leased and partnership international theatres, or approximately 90% of its international circuit, after having suspended operations at all international theatres for approximately four months beginning in late February 2020. During the fourth quarter ended December 31, 2020, in response to federal and local government mandates related to a global resurgence of COVID-19, nearly all of AMC's international theatres suspended operations. As of December 31, 2020, AMC was operating at 109 international leased and partnership theatres, with limited seating capacities, representing approximately 30% of international theatres and 17% of 2019 international same-theatre revenue."

16:15 EST Redwood Trust raises quarterly dividend 14% to 16c from 14c per share - The first quarter 2021 dividend is payable on March 31 to stockholders of record on March 24.

16:13 EST Cloudera says 'Cloudera Data Platform demonstrated significant momentum' in Q4 - "Cloudera Data Platform demonstrated significant momentum in the quarter," said Rob Bearden, CEO, Cloudera. "Customers migrating to CDP increased from about 10% of our customer base at the time we reported Q3 to more than 15% of our customer base today. Most impressively, ARR from CDP now exceeds $60 million of total ARR. The adoption of CDP for hybrid data cloud and data lifecycle use cases is what will drive future growth and we're very happy with this progress to date."

16:12 EST Oracle CEO says 'we continued to extend our huge lead in the cloud ERP market' - "We continued to extend our huge lead in the cloud ERP market as Fusion ERP grew 30% and NetSuite ERP grew 24% in Q3," said Oracle CEO, Safra Catz. "Oracle's rapidly growing highly-profitable, multi-billion dollar cloud ERP businesses helped drive subscription revenue up 5% and operating income up 10% in the quarter. Subscription revenue now accounts for 72% of Oracle's total revenues, and this highly-predictable recurring revenue-stream along with expense discipline are enabling double-digit increases in non-GAAP earnings per share." "Once again in Q3, Oracle's Gen2 Cloud Infrastructure business added customers, and grew revenue at a rate in excess of 100%," said Oracle Chairman and CTO, Larry Ellison. "We are opening new regions as fast as we can to support our rapidly growing multi-billion dollar infrastructure business. On the applications front, analysts continue to rank Oracle the clear number one in cloud ERP, and this quarter Oracle signed contracts totaling hundreds of millions of dollars to migrate several more large companies from SAP ERP to Oracle Fusion ERP."

16:09 EST Moderna says first participants dosed in modified COVID-19 vaccine study - Moderna announced that the first participants have been dosed with the company's modified COVID-19 vaccines, designed to address the potential need for booster vaccine candidates, in an amendment to the ongoing Phase 2 clinical study. mRNA-1273.351 encodes for the prefusion stabilized Spike protein of the SARS-CoV-2 variant B.1.351, first identified in the Republic of South Africa, and is being assessed as a booster vaccine to increase the breadth of response to emerging variants with key-receptor-binding domains mutations. mRNA-1273.211 is a multivalent candidate which combines mRNA-1273, Moderna's authorized vaccine against ancestral strains, and mRNA-1273.351 in a single vaccine, designed to elicit a broad immune response as both a primary series and when administered as a boost to those who have previously received mRNA-1273.

16:08 EST GigCapital2 gets stockholder approval of extension to complete combination - GigCapital2 announced that its stockholders approved an extension of the date by which it has to consummate a business combination from March 10, 2021 to June 10, 2021. GigCapital2 requested the extension to allow more time to complete its previously announced business combinations with UpHealth Holdings, Inc. and Cloudbreak Health, LLC as it pertains solely to the finalization of the S-4 documents filed with United States Securities and Exchange Commission on February 8, 2021.

16:06 EST Oracle reports Q3 Cloud license and on-premise license revenues $1.3B, up 4%

16:04 EST Velodyne Lidar founder Hall refutes statements made in recent 8K filing - David Hall, the beneficial owner of approximately 98,506,156 shares or 54.7% of the outstanding common stock of Velodyne Lidar issued the following letter to the company's Board of Directors regarding his decision to resign from the Board: am writing to you today to directly refute the statements regarding my resignation from the Board included in Velodyne Lidar's (the "Company") recent Form 8-K filing. These statements do not accurately depict why I resigned and instead focus on the Company's decision to publicly censure Marta Hall and I based on unfounded claims which we strongly refute. To be completely clear: I chose to resign from the Board because I had numerous concerns about the strategic direction and current leadership of Velodyne Lidar. As the founder and former Chief Executive Officer of Velodyne Lidar, I oversaw years of growth and success that ultimately laid the groundwork for the Company to go public via a merger with a special purpose acquisition company ("SPAC") in 2020. Despite serving as the Executive Chairman of the Board following Velodyne Lidar's successful SPAC merger, it became quickly apparent to me that Jim Graf and Michael Dee - joint founders of the SPAC - wanted to curtail my involvement in the quality and selection of products being developed, the contracts negotiated and integrity of the Company's business moving forward. These actions, in my view, emboldened Chief Executive Officer Anand Gopalan to disregard my views. I firmly believe that the Board has fostered an anti-stockholder culture and that Velodyne Lidar's corporate governance is broken. Perhaps most unsettling was the Board's decision to rubberstamp an increased compensation package for Mr. Gopalan despite the Company releasing weak Q4 2020 earnings and missing year end forecasts. The Board also recently attempted to manipulate the Company's corporate machinery by transitioning Christopher Thomas from a Class I director to a Class II director in an apparent move to avoid having him stand for re-election against my nomination of Eric Singer, a highly-qualified director candidate with significant public board experience. As a whole, I believe the status quo in Velodyne Lidar's boardroom is unacceptable. The Board lacks prior public company experience, seems to prioritize its own self-interests over stockholders and has overseen the destruction of significant stockholder value. It was in light of these serious concerns - as well as the Board's complete disregard for my decades of experience and input - that made me come to the difficult decision of submitting my resignation last week. Unfortunately, the Board as currently constituted appears to have no respect for the principles, values and culture that I spent years building at Velodyne Lidar. My wife, Marta Hall, will remain on the Board and continue to perform her fiduciary duties to best serve all Velodyne Lidar stockholders."

16:02 EST TFF Pharmaceuticals reports Q4 EPS (26c), consensus (23c) - CEO Glenn Mattes says: "Our internal development programs are progressing ahead of expectations, as we are seeing very positive clinical results in both Phase 1 trials for our Voriconazole Inhalation Powder program, to treat the severe and life-threatening disease of Invasive Pulmonary Aspergillosis, as well as for our Tacrolimus dry-powder program for the prevention of lung transplant rejection. Final data for our Voriconazole product, the first-ever clinical study of a direct-to-lung, Thin Film Freezing (TFF) dry-powder formulation, resulted in blood levels greater than two-fold higher than those shown to clear complex IPA infections, with no significant adverse events. And our Tacrolimus product was able to reach therapeutic blood levels of 5-16 ng/mL in all patients from a single inhaled dose of 5 mg of our reformulated Inhalation Powder, without significant adverse events. Both these very significant results bode well for our upcoming pivotal trials for these drugs, which address large markets with unmet needs. We are also honored to announce today a strategically important contract for the Company with a major government research agency to formulate dry powder versions of a suite of biological countermeasures that is intended for use by our nation's military forces. This is another meaningful event for TFF as we continue to build our portfolio of development agreements with pharmaceutical companies, the government and academia. We look forward to providing more details on this contract pending security review and approval of further news distribution from the government and the prime contractor. And our ubiquitous and disruptive Thin Film Freezing technology continues to garner considerable attention from potential industry partners. With the potential to mitigate the need for cold chain storage and distribution of vaccines, as well as the first-of-its-kind capability to reformulate large, complex biologic molecules, thin film freezing has generated strong interest from biotechnology companies, as well as some of the largest developers of vaccines and anti-virals."

15:32 EST Velodyne, Qualcomm, NavVis partner over smart city applications - Velodyne Lidar (VLDR), NavVis and Qualcomm Technologies (QCOM) are joining forces to help governments and solution developers create smart city applications that can improve infrastructure and public services, and enhance safety and quality of life. Velodyne and NavVis, an Automated with Velodyne partner, are both members of the Qualcomm Smart Cities Accelerator Program, which connects cities, municipalities, government agencies and enterprises with an ecosystem of providers. NavVis technicians scanned 220,000 square feet of the campus using the NavVis VLX wearable mapping system equipped with two Velodyne Lidar Puck LITE sensors to provide high-quality data capture of 3D measurements. NavVis VLX combines Velodyne image data with NavVis simultaneous localization and mapping technology to deliver survey-grade point clouds with a mobile device. Velodyne, NavVis and Qualcomm Technologies have created a smart building solution showcase on Qualcomm's Morehouse campus in San Diego to demonstrate how their technologies work together in a digital twin application. Using the NavVis smart building application, tasks like floor layout, repair and maintenance, and smart safety and security measures can easily be performed without the needs to be physically onsite. The system provides users a full 360-degree view and digital representation of the building. The model is highly accurate, allowing viewers to zoom into points of interest within the space.

15:21 EST Schlumberger's Merad sells 40,000 common shares - In a regulatory filing, Schlumberger EVP of Performance Management Abdellah Merad disclosed the sale of 40,000 common shares of the company on March 9 at a price of $29.439 per share.

15:06 EST AVEO Oncology trading resumes

14:55 EST Aveo Pharmaceuticals receives FDA approval for tivozanib - Aveo Pharmaceuticals was granted FDA FDA approval for tivozanib, according to a post the agency's website. Reference Link

14:46 EST Quidel slips, drags on peers as demand for testing 'softens significantly' - Shares of Quidel (QDEL) are under pressure on Wednesday after the company said demand for testing was down 30%-40% quarter-to-date versus the fourth quarter and that it sees quarterly revenue of "at least" $450M, with consensus estimates at roughly $755M. The guidance also sent shares of several peers, including Qiagen (QGEN) and Fulgent Genetics (FLGT), into negative territory. DEMAND DOWN: During Barclays' Global Health Virtual Conference, Quidel said that testing in February and March has "softened significantly," with demand for testing down 30%-40% quarter-to-date versus the fourth quarter. The company also noted that it sees revenue of "at least" $450M for the quarter, with consensus at $755.07M. For the current fiscal year, Quidel sees revenue of roughly $2.5B, with consensus at $2.87B. PRICE ACTION: In afternoon trading, shares of Quidel have dropped over 16% to $130.75. Also lower, Qiagen has slipped almost 4% to $45.84, Fulgent Genetics has plunged over 12% to $96.09, GenMark (GNMK) has slid more than 18% to $16.31, PerkinElmer (PKI) has slipped over 4% to $120.57, Becton Dickinson (BDX) has slid about 2% to $237.50, and Opko Health (OPKO) and Hologic (HOLX) have dropped about 5% apiece to $4.31 and $68.47, respectively.

14:21 EST Manulife Financial reports 'favorable' appeal court ruling in Mosten case - Manulife Financial provided the following statement in connection with the "favorable" Saskatchewan Court of Appeal ruling in the Mosten Investment LP case: "We are pleased with the Court of Appeal's ruling prohibiting unlimited deposits into universal life insurance contracts in Saskatchewan. The Court affirmed that the Government of Saskatchewan regulation applies to all universal life policies, including the policies that are at issue in this litigation. The decision confirms that policyholders cannot make unlimited deposits into universal life insurance contracts and makes clear deposits must relate to amounts required to pay the life insurance premium. As we have previously stated, we were always confident we would ultimately prevail in this matter and that it would not have any material impact on the company's business."

13:36 EST CEO Rawlinson says Lucid Motors 'good financially' until 2023 - Speaking at the 2021 B. Riley Securities Sustainable Energy & Technology Conference, Lucid Motors CEO Peter Rawlinson said the company's first product, the Lucid Air, is on track for expected production and deliveries in the second half of 2021. "We're in very good shape financially, we're good until early part of 2023 before Gravity gets into production," Rawlinson says. "We will aim to get profitable when the time is right."

13:34 EST Quidel plunges 20% to $136 during Barclays conference presentation

13:32 EST Quidel: Demand for testing down 30%-40% QTD vs. Q4

13:28 EST Quidel falls 11% to $138.64 during Barclays conference presentation

12:39 EST GameStop down $30.90, or 13%, to $216 after several trading halts - GameStop shares, which had been higher is early trading, are having another volatile session.

12:22 EST GameStop trading halted, volatility trading pause

12:01 EST New Oriental Education falls -10.7% - New Oriental Education is down -10.7%, or -$19.84 to $166.09.

12:00 EST Tupperware Brands falls -22.1% - Tupperware Brands is down -22.1%, or -$7.15 to $25.25.

12:00 EST GameStop rises 30.1% - GameStop is up 30.1%, or $74.42 to $321.32.

11:47 EST Alphabet's Waymo expands Waymo Open Dataset - Alphabet's Waymo said it is expanding the Waymo Open Dataset with the publication of a motion dataset - which the company believes to be the largest interactive dataset yet released for research into behavior prediction and motion forecasting for autonomous driving. "We're also announcing the next round of Waymo Open Dataset Challenges - with cash awards - to help encourage new research into both perception and behavior prediction," the company said. "Finally, we're releasing a paper describing the state-of-the-art research offboard perception method we used to annotate the motion dataset, so any research team can consider our techniques when exploring ways to create their own high-quality motion data." Reference Link

11:03 EST Titan Aircraft, Icelandair enter long-term agreement for Boeing aircraft - Titan Aircraft Investments, the joint venture between Titan Aviation Holdings and Bain Capital Credit, announced the acquisition of two Boeing (BA) 767-300ER aircraft from Icelandair. These aircraft will be converted to freighters and placed on long-term leases to Icelandair. Titan Aviation Holdings, a subsidiary of Atlas Air Worldwide Holdings (AAWW), will manage these assets. With the addition of these two 767s, Titan Aircraft Investments' portfolio has grown to three aircraft, which also includes a 777-200 freighter. Titan Aircraft Investments' aircraft portfolio is managed by Titan Aviation Holdings.

10:23 EST Westport announces successful startup, trials of hydrogen-fueled ICE system - Westport Fuel Systems announced the successful startup and initial trials of a heavy-duty internal combustion engine running on hydrogen fuel, using its patented and proprietary High Pressure Direct Injection 2.0 System. "We believe H2-HPDI could be extremely compelling, with near-zero greenhouse gas emissions and much lower cost than fuel cell vehicles or battery electric vehicles, particularly for heavy-duty trucking and other high-load applications like mining, marine and rail that have come to rely on the efficiency, power, durability and reliability of diesel engines. While there is more work to be done, our initial test results are encouraging and a testament to our team's ongoing commitment to innovation," said David Johnson, CEO of Westport Fuel Systems.

10:01 EST Posco falls -8.1% - Posco is down -8.1%, or -$5.64 to $64.17.

10:01 EST Tupperware Brands falls -22.5% - Tupperware Brands is down -22.5%, or -$7.30 to $25.10.

10:01 EST Tupperware Brands falls -22.7% - Tupperware Brands is down -22.7%, or -$7.37 to $25.03.

10:01 EST Laix rises 15.9% - Laix is up 15.9%, or 43c to $3.14.

10:01 EST Washington Prime rises 24.9% - Washington Prime is up 24.9%, or 84c to $4.24.

09:57 EST GE Capital to see smaller loss in 2021

09:48 EST 3M awarded contract by Michigan Medicine for AI-powered revenue cycle tech - Michigan Medicine will partner with 3M Health Information Systems to implement a full portfolio of 3M technology across its health care system. Powered by artificial intelligence, 3M's clinician and revenue cycle solutions will help Michigan Medicine reduce physician stress and bolster thorough clinical documentation, strengthening communication between clinicians and revenue cycle teams to promote accurate and actionable data for improved patient care, the company said in a statement. 3M's suite of AI-enabled solutions, fully integrated with Michigan Medicine's electronic health record, will be implemented across the health system's three hospitals and 125 outpatient clinics, including the University of Michigan Health System and Medical School, one of the state's largest health care complexes.

09:33 EST Parsons invests in emerging contaminants solutions - Parsons Corporation announced that it is continuing to invest in solutions to manage, mitigate and remediate per- and polyfluoroalkyl substances, a significant environmental and public health concern that has been found in drinking water sources above the Environmental Protection Agency and individual state health advisory levels. Parsons' research and development investments for the emerging contaminants market includes leveraging data analytics and machine learning for improved risk identification and mitigation; evaluating new technologies to more quickly and effectively detect PFAS; and developing new treatment technologies, including three patent-pending solutions for destruction of PFAS. Additionally, the company is currently expanding its environmental treatability lab in Syracuse, New York, which oversees Parsons' cutting-edge PFAS research.

09:16 EST Chicken Soup for the Soul's Crackle Plus signs agreement for Vewd smart TVs - Chicken Soup for the Soul Entertainment announced Crackle Plus signed an agreement to launch the Crackle app on Smart TVs and set-top boxes powered by Vewd, the leading provider of OTT and hybrid TV solutions. Shipping on almost 40 million connected TVs, set-top boxes, game consoles, and cars each year, Vewd powers the app store, home screen, and promotion experiences on such brands as Sony, Hisense, Vestel, Vodafone, Swisscom, as well as many others.

09:11 EST General Electric sees positive Renewable Energy margins by 2022

09:08 EST Natera and Genentech initiate Phase 3 trial of Signatera test - Natera (NTRA) announced that the first patient has been screened in a new phase III clinical trial that uses its tumor-informed, personalized molecular residual disease - MRD - test, Signatera, as a companion diagnostic to identify muscle-invasive urothelial carcinoma patients eligible for investigational treatment with Genentech's, a member of the Roche (RHHBY) group, cancer immunotherapy drug atezolizumab. The IMvigor011 study, sponsored by Genentech, is a global, randomized, placebo-controlled, phase III clinical trial to evaluate the safety and efficacy of adjuvant treatment with the PD-L1 inhibitor, atezolizumab, in patients with MIUC who are MRD-positive after surgery. The first approximately 500 patients who test MRD-positive will be enrolled and randomized to receive either atezolizumab or placebo for 12 cycles, or up to one year. The primary endpoint of the study will be disease-free survival. In an exploratory analysis from the phase III trial presented in December 2020, the 37% of patients who tested MRD-positive with Signatera after surgery experienced significant benefit from adjuvant atezolizumab vs. observation, while the 63% of patients who tested MRD-negative experienced zero treatment benefit. In an independent study of 68 patients with MIUC in 2019, Signatera detected relapse with 100% sensitivity and 98% specificity, reporting a median lead time of 96 days.

09:07 EST VivoPower enters contract to complete electrical works for Blue Grass Solar Farm - VivoPower announced that its wholly-owned subsidiary in Australia, J.A. Martin Electrical has recently been awarded a contract to complete all electrical works for the 200 MW Blue Grass Solar Farm located near the town of Chinchilla in the Australian state of Queensland. The project will be the third Australian solar farm completed by J.A. Martin in partnership with lead EPC contractor GRS and brings J.A. Martin's total of completed and contracted solar farms to over 350 MWdc. Once energized, the Blue Grass Solar Farm will generate approximately 420,000 MWh of clean energy per year, enough to power 80,000 homes, and avoid over 320,000 tonnes of carbon dioxide emissions annually, the equivalent of approximately 130,000 vehicles. The project's construction will create about 400 local jobs.

09:06 EST Fortinet says Fortinet Security Fabric reaches over 400 integrations - Fortinet announced the Fortinet Security Fabric has reached more than 400 technology integrations in its Open Fabric Ecosystem, to further deliver end-to-end security with broad visibility and seamless management through integrated, pre-validated solutions. These integrations are made possible through Fortinet's Fabric-Ready Partner Program, made up of strategic partnerships with industry-leading organizations to offer pre-validated solutions that provide advanced security and enhanced visibility across the entire digital infrastructure.

09:04 EST Fortinet expands Fortinet Engage Partner Program benefits - Fortinet announced updates to the Fortinet Engage Partner Program, enabling additional flexibility and revenue growth for partners. Fortinet is adding new consumption models for a range of products including FortiSIEM and FortiEDR, enhancing benefits for cloud partners and introducing new Specializations focused on growing markets. With hybrid workforces, highly distributed network infrastructures and new digital innovations, organizations find that securing all their environments is becoming increasingly complex if they don't have the right technology and trusted advisors to lean on. To further enable channel partners to address these customer needs, the Engage 2.0 Partner Program will now include: New Consumption Models: Fortinet is continuing to enable MSSP and SP partners to build services and grow their business leveraging the Fortinet Security Fabric with new consumption models for FortiSIEM, FortiEDR, FortiClient, FortiSOAR, FortiAI and FortiDeceptor. According to Gartner, by 2024, more than 90% of buyers looking to outsource to security services providers will focus on threat detection and response services. Fortinet has seen an uptake of our consumption offerings, which continues to grow significantly as partners take advantage of tapping into this market demand for threat detection security outcomes. With more and more customers looking for flexible consumption models, the introduction of new ways to consume Fortinet's end point solutions enable MSSPs and SPs to offer their customers new security services that can be quickly deployed and at lower costs. Enhanced Cloud Partner Benefits: The Engage Partner Program allows partners to engage as an integrator, MSSP or cloud partner. For cloud partners, Fortinet is adding additional ways they can take advantage of the various routes to market leveraging Fortinet's Adaptive Cloud Security offerings. Managed cloud service provider partners are now immediately eligible for the Engage Select Cloud Business Model. Participants in this business model are eligible for additional discounts on Fortinet's flexible licensing models, including BYOL and pay-as-you-go, and gain access to FortiCWP and FNDN. These new benefits result in cost savings as partners expand their cloud security services powered by Fortinet. Additional Specializations: Fortinet is introducing new Specializations focused on high growth areas with additions including: Zero Trust Access, Operational Technology and Security Operations. Specializations help partners further distinguish their expertise among current and potential customers as trusted partners who have the knowledge, services and technologies to fulfill customer business needs. Fortinet's existing Specializations have included Secure SD-WAN, Data Center, Adaptive Cloud Security, and LAN Edge and SD-Branch. Updated NSE Courses to Meet Compliance Requirements: Fortinet's NSE training courses and eight-level Certification Program, which are free to all Fortinet partners, have been updated allowing partners to meet more compliance requirements.

09:02 EST Qualcomm increases dividend 5% to 68c per share - Qualcomm has approved a 5% increase in the company's quarterly cash dividend. The quarterly cash dividend will increase from 65c to 68c per share of common stock and will be effective for quarterly dividends payable after March 25, 2021. This dividend increase will raise the annualized dividend payout to $2.72 per share of common stock.

09:00 EST Campbell Soup says 'well-positioned to generate significant cash flow' - Says capital priorities "remain the same."

09:00 EST Bryn Mawr Bank trading resumes

08:52 EST General Electric has 'significant' sources of funds to lower debt, CFO says

08:43 EST Solarwindow appoints John Rhee as president - SolarWindow Technologies announced the planned appointment of Company Director, Mr. John Rhee, to President of SolarWindow. Mr. Rhee additionally continues to serve as President of the Company's Asian subsidiary where he has actively established SolarWindow operations, strengthened and expanded the management team, and supported important technology advancements.

08:40 EST Longeveron, University of Miami expand license agreement, enter CRADA - Longeveron announced that the Company has expanded and amended its exclusive license agreement related to Lomecel-B technology rights, and entered into a Collaborative Research and Development Agreement with the University of Miami. On November 20, 2014, the Company entered into an ELA with UM for the use of medicinal signaling cell technology rights developed at UM by the Company's Chief Science Officer, Joshua Hare, M.D., who is also founding director of the Interdisciplinary Stem Cell Institute at the UM Miller School of Medicine. The expanded and amended ELA includes the following: Two Investigational New Drug applications, and all associated research data: BB-IND 15,679: allogeneic human mesenchymal stem cells for Aging Frailty, BB-IND 16,045: allogeneic human mesenchymal stem cells for treatment of Hypoplastic Left Heart Syndrome Patent application for methods for treating endothelial dysfunction; Exclusive option to obtain a license to additional intellectual property related to treatment of HLHS and dilated cardiomyopathy; Modification of milestone payments and payment deadlines owed to UM.

08:38 EST Cyclo Therapeutics appoints Russ Belden as acting Chief Commercial Officer - Cyclo Therapeutics today announced the appointment of Russ Belden as Acting Chief Commercial Officer. "We are committed to driving our pipeline forward and are laser focused on advancing Trappsol Cyclo toward regulatory approval, most immediately for the treatment of NPC. As we commence our pre-commercialization activities, Russ' experience, expertise and leadership will be pivotal as we drive forward our programs addressing indications with significant unmet need," commented N. Scott Fine, CEO of Cyclo Therapeutics.

08:37 EST Sysco announces $1.1B debt reduction - Sysco Corporation announced it had reduced its outstanding debt by a total of $1.1 billion. On March 9, the company repaid the remaining $700 million in outstanding borrowings under its long-term revolving credit facility that expires on June 28, 2024. In addition, on March 10, Sysco's United Kingdom-based subsidiary, Brake Bros Limited, repaid EUR300 million of its EUR600 million in aggregate principal amount of notes outstanding under its commercial paper program, equating to approximately $417 million in debt reduction. The debt payments were funded from cash on hand, and will reduce interest expense by approximately $15M annually.

08:36 EST LMP Automotive announces release of e-commerce website - LMP Automotive Holdings announced the release of its next generation, integrated e-commerce website, lmpmotors.com. Highlights include: Integrated consumer-facing inventory, automated geographical delivery fees, expanded free delivery radius; Fast and seamless onboarding of customers; Automated driver's license check, credit approval, payment and end user customer management functions; Choose vehicle - Choose purchase or subscription-lease - Scan driver's license - Apply - Get it delivered or pick up from store.

08:34 EST aTyr Pharma appoints Judith Varner as scientific advisor - aTyr Pharma announced the appointment of Judith Varner, Ph.D., as a scientific advisor to the company. Dr. Varner currently serves as Professor in the Departments of Pathology and Medicine at the Moores Cancer Center at the University of California, San Diego.

08:33 EST WSFS Financial to combine with Bryn Mawr Bank in $976.4M transaction - WSFS Financial Corporation (WSFS) and Bryn Mawr Bank Corporation (BMTC), jointly announced today the signing of a definitive merger agreement whereby Bryn Mawr Bank Corporation will merge with WSFS Financial Corporation, in a transaction valued at approximately $976.4 million. Simultaneously with the merger, The Bryn Mawr Trust Company, the wholly owned subsidiary of Bryn Mawr, will merge into WSFS Bank, a wholly owned subsidiary of WSFS. The combination of two of the high performing, locally-based financial services companies in the Greater Philadelphia and Delaware region solidifies WSFS' position as the preeminent, locally-headquartered bank for this region. With nearly $20 billion in assets and an approximately $43 billion Wealth Management business as of December 31, 2020, WSFS believes that following the merger it will be the only bank in the region with distinct market-share advantages, including market knowledge, local decision-making, a full-service product suite and a balance sheet to compete with larger regional and national banks. Under the terms of the agreement, stockholders of Bryn Mawr will receive 0.90 of a share of WSFS common stock for each share of Bryn Mawr common stock. The per share value equates to an implied value of $48.55 for Bryn Mawr stockholders based on the closing price of WSFS stock on March 9, 2021. WSFS anticipates consolidating approximately 30% of the combined banking offices due to geographic overlap and optimization opportunities within the network. WSFS expects pre-tax merger and restructuring costs of approximately $127 million and to achieve annual cost synergies of approximately $73 million, once fully phased in by 2023. The merger is expected to be accretive to WSFS' earnings per share in 2022, excluding the one-time merger and restructuring costs noted above, and 13.4% accretive once all synergies are achieved in 2023, generating an internal rate of return of approximately 18.0%. After closing, Frank Leto, President and CEO of Bryn Mawr, will join the Boards of Directors of WSFS Financial and WSFS Bank along with two mutually agreed upon current directors of Bryn Mawr's Board. The merger agreement has been approved by the boards of directors of both companies. Closing of the transaction is subject to customary approvals by regulators and stockholders of both companies. Pending those approvals, the transaction is expected to close early in the fourth quarter of 2021.

08:32 EST B&G Foods extends up to $50M stock repurchase program into 2022 - B&G Foods announced that its board of directors has authorized an extension of the company's stock repurchase program through March 15, 2022. Under the authorization, the company may purchase up to $50M of shares of the company's common stock from time to time in the open market or in privately negotiated transactions in compliance with the applicable rules and regulations of the Securities and Exchange Commission.

08:32 EST T. Rowe Price reports preliminary AUM $1.5T at February 28 - Client transfers from mutual funds to other portfolios, including trusts and separate accounts, were $1.1B in February 2021 and $3.9B for the quarter-to-date period ended February 28, 2021. These client transfers include $1.1B and $3.6B, respectively, transferred to the target-date retirement trusts during February and the year-to-date period.

08:29 EST Campbell Soup says Q3 to be 'somewhat more challenged' than Q4 - Expects Q3 to be "somewhat more challenged" than Q4 from a sales/EBIT perspective. Sees Q3 impacted by "isolated supply challenges."

08:28 EST General Electric to lower receivables factoring to $2B from $7B

08:27 EST Dorman Products announces over 170 new replacement auto parts - Dorman Products is announcing the release of more than 170 new replacement auto parts, extending Dorman's aftermarket coverage in several key categories, and giving repair shops and vehicle owners greater freedom to fix cars and trucks with innovative and trustworthy solutions. Dorman continues to expand its aftermarket-exclusive offerings of replacement transmission oil cooler lines, adding six new parts that cover a combined 2 million+ SUVs and cars. Two of the new replacement lines are engineered to better protect transmissions on select Dodge Durango, Jeep Wrangler and Jeep Grand Cherokee model years by incorporating a specially designed thermostatic valve that helps resist leaks, ensure faster operating temperature and maximize coolant flow. Another exclusive transmission line replaces the factory part on aging Chevrolet Cruze models, and features a durable and reliable design that resists hose separation at pressure levels up to 500 PSI. These new releases bring Dorman's catalog of transmission lines to more than 370 products.

08:26 EST Cocrystal Pharma extends drug discovery collaboration with HitGen, InterX - Cocrystal Pharma announces an extension of its drug discovery collaboration with HitGen, a biotech company with an innovative DNA Encoded Library technology, and InterX Inc., a computer software company with a biomolecular simulation for drug discovery. The collaboration was initiated in September 2017 and will now continue through August 2023. Through this collaboration, Cocrystal, HitGen and InterX scientists are applying HitGen's DNA-encoded library technology platform, Cocrystal's structure-based drug discovery platform technology, and InterX's computational science to develop novel antiviral lead candidates. The DEL technology combines the power of molecular biology, combinatorial chemistry, high throughput sequencing and advanced informatics to identify potential drug candidates. Cocrystal applies its technology to determine the cocrystal structures of the potential drug candidates identified from the DEL library. This structural information is then combined with InterX's advanced computer algorithms to predict inhibitor-target interactions. A Joint Steering Committee comprised of representatives from all three companies is overseeing the collaboration.

08:24 EST mdf Commerce enters five-year renewal agreement with APC - mdf commerce announces a five-year renewal agreement with Alutiiq Professional Consulting. APC is a sister company to Alutiiq, a premier Alaska Native Corporation-owned company whose subsidiaries are leading providers of specialized services to the US Federal Government. The renewed mdf commerce contract lifecycle management solution for APC has dramatically improved team collaboration and operational efficiency.

08:23 EST Intercept CFO Sandip Kapadia to depart - Intercept Pharmaceuticals announced that Sandip Kapadia, CFO, will leave Intercept to pursue another opportunity. Mr. Kapadia will continue to serve as CFO until his departure on March 26, 2021. The Company also announced Mr. Rocco Venezia will be appointed Chief Accounting Officer and will serve as acting CFO until a permanent replacement is announced.

08:21 EST Daseke announces term loan refinancing - Daseke announced that it has refinanced its existing $484 million Term Loan B due February 2024 with a new $400 million Term Loan B and available cash. The new Term Loan B, maturing in March 2028 has a floating interest rate of LIBOR + 400 basis points, which is reduced from LIBOR + 500 basis points. The transaction closed on March 9, 2021. In addition, the Company will seek an amendment to its ABL credit agreement to increase maximum commitments thereunder from $100 million to $150 million, with a $50 million uncommitted accordion. Transaction Highlights: Company to utilize $84 million of its $176 million cash and cash equivalents balance as of December 31, 2020 to pay down debt, which was driven by excess cash generated from operations over the course of the previous year; Significantly reduced cash interest expense under new Term Loan; Extends maturity on the Company's debt from 2024 to 2028; Creates additional financial flexibility through improved covenant-lite structure; Further strengthens the balance sheet and provides capacity for organic and strategic growth investments; Upon close, the Company's estimated net debt leverage ratio as defined by its credit agreement will be approximately 2.7x based on the terms of the credit agreement. In connection with the refinancing, on February 23, 2021, Moody's Investment Services upgraded Daseke's corporate family and senior secured ratings to "B2" from "B3," and S&P Global provided a one-notch upgrade Daseke's issuer credit family and term loan ratings to "B".

08:20 EST Bragg Gaming enters revenue sharing agreement with Premier Gaming - Bragg Gaming is pleased to announce that wholly-owned subsidiary ORYX Gaming has signed a licensing agreement with Premier Gaming to provide both its library of games and its world-class player engagement platform. Premier Gaming operates multiple online gambling brands, including Pronto Casino, Slothino, Premier Live Casino and Pronto Live Casino. Active in jurisdictions globally, including Sweden, Finland and Germany, Premier addresses a multi-billion market. Under the licensing agreement, Premier Gaming has access to an extensive library of games from ORYX's exclusive RGS providers, including GAMOMAT, Kalamba Games, Givme Games, Golden Hero, CandleBets, Peter & Sons and Arcadem. Premier will also employ ORYX's player engagement platform, featuring tools that have been proven to increase engagement and prolong player sessions, including real-time leaderboards, tournaments, achievements and jackpots. The combination of unique and local content and ORYX engagement tools have proven to significantly increase player retention and player values. Content from premium third-party suppliers, including Greentube, Pragmatic Play and iSoftBet, will also be added to Premier Gaming's online casinos via Bragg's ORYX Hub.

08:18 EST Camping World to acquire Nielson RV in Utah - Camping World announced that an agreement has been signed to acquire Nielson RV. The agreement includes two RV Dealership locations, one residing in St. George, Utah and a second in Hurricane, Utah. The deal is anticipated to close in Spring. The SuperCenters will include a wide range of new and used RVs from manufacturers in addition to an assortment of RV and outdoor products and accessories. Camping World will have five locations in Utah once the acquisitions are complete.

08:16 EST Campbell Soup says 'thrilled' with performance of Pacific Foods - Says "very excited" about breadth of Snacks pipeline. Says additional room to improve profitability of Snacks business. Comments taken from Q2 earnings conference call.

08:16 EST Tattooed Chef launches six plant-based products at Target stores - Tattooed Chef (TTCF) announced that six of its beloved plant-powered products will be newly available for purchase in Target (TGT) stores nationwide starting Monday, March 15, 2021. These bowls are available in the frozen section at Target retailers nationwide. They require a one-step preparation and are ready to eat within 6-7 minutes. Each product starts at $4.99 per bowl.

08:14 EST Global Internet of People enters partnership with China Policy Expert Database - Global Internet of People announced that its subsidiary, Global Mentor Board Science and Technology Ltd. Co., has entered into a strategic partnership framework agreement with China Policy Expert Database, a research institute owned by China Yan Shi Press, a state-owned publisher in China, on January 14, 2021. The strategic partnership aims to provide Chinese entrepreneurs with various services such as policy interpretation, economic trend analysis, strategic interpretation, and industrial research. Pursuant to the Framework Agreement, which is valid for twenty four months, the two parties intend to jointly develop and promote SDH's certain projects, undertake local government and enterprises-assigned research projects, and provide "one-on-one" policy consulting services to clients; host conferences and seminars to promote economic and business development; and hold study sessions on policy interpretation and analysis. Fees and profit sharing arrangements relating to the specific projects and undertakings under the Framework Agreement will be determined by the parties via separate agreements.

08:11 EST Vera Bradley announces four key growth drivers for 2022 - CEO Rob Wallstrom commented, "Our enterprise's forward-looking strategy is to be a purpose-driven, multi-lifestyle brand, high-growth company, and we are just beginning the journey. Our strong cash position, debt-free balance sheet, and ability to generate free cash flow will allow us to seek out appropriate acquisitions of other comfortable, affordable, purpose-driven, digitally-native brands, similar to our successful Pura Vida acquisition, over time. We will also expand our reach by adding adjacent product categories and geographies. For Fiscal 2022, the Company's four key growth drivers are: Driving our digital-first strategy, by evolving the digital distribution of our products and further refining and utilizing digital experiences to serve our customers. This will be supported by continuously refining our technology, developing business process and technology platforms to improve agility, data-based decision making, customer centricity, and speed-to-market. Enhancing our product innovation pipeline, collaborations, and category extensions to attract new customers and increase share of wallet with existing customers. Building our community, through marketing and by creating an impactful, positive brand movement that not only changes lives but deepens her brand loyalty. Evolving our distribution channels, by focusing on future growth opportunities and addressing the drastically changing retail environment and the consumer marketplace. We have a long-term vision for the future of our Company and a clear path to achieve our goals. Our team is focused, our balance sheet is solid, our brands are strong, and we are positioned for growth. We are excited about the possibilities for Vera Bradley, Inc."

08:10 EST Vera Bradley appoints Darren Hull as brand president - CEO Rob Wallstrom noted, "Today, we are also announcing changes to the leadership structure of our Company and the Vera Bradley brand to position us for an exciting future. As we conclude Vision 20/20, we are embarking on the next important phase of our Company's growth by enhancing our multi-brand portfolio, further expanding our ESG initiatives, and driving additional value for all of our stakeholders. In order to strengthen our position and strategic vision as a purpose-driven, multi-brand, high-growth company, we are realigning our organizational and leadership structure. Vera Bradley and Pura Vida are the two lifestyle brands currently under our Vera Bradley, Inc. umbrella. We not only intend to nurture and grow both of those brands, but we will also look for other lifestyle brands that could strengthen our capabilities and diversify our revenue streams. While I will continue as CEO of Vera Bradley, Inc., each brand will have their own leadership team that will focus on building customer engagement and expanding revenue, while protecting and cultivating the distinct ethos and entrepreneurial spirit of each unique brand. With the retail industry continuing its rapid transformation into a customer-centric, data-driven, technology-enabled, and digitally-driven industry, Vera Bradley will double down on these focus areas. Serving as Vera Bradley's Chief Customer Officer for the past two and a half years, Daren Hull and his team have already radically strengthened the way we engage with our customers. Now, Daren Hull has been appointed as the Vera Bradley Brand President and will continue to lead our digital-first transformation. In his new role, Daren is being supported by a new streamlined leadership structure focused on three critical areas: what we bring to market, how to sell the market, and how we raise customer engagement and interest in the brand." On a corporate level, we will offer consolidated back-office support and an efficient and lean corporate platform to enhance the growth of each brand. We will continue our technology and customer insights evolution to build an integrated ecosystem of capabilities on an enterprise level that will allow our brands to respond more quickly to our customers' wants and needs. These changes will better prepare us to adapt to the ever-changing retail landscape, allow us to better react to customer needs, strengthen our positioning, and propel us toward more profitable growth. I am so proud of all that the teams have accomplished over the past year. I am confident that we have an exciting future ahead as we are poised to take advantage of additional acquisition opportunities and to evolve into an even more modern and relevant multi-brand retailer."

08:08 EST Thermo Fisher investing over $600M to expand bioprocessing production - Thermo Fisher announced more than $600M in capital investments to expand its bioprocessing production capabilities through 2022. These investments are expected to more than double the company's current manufacturing capacity and support biopharma customers as they ramp up to meet both the short-term demands related to COVID-19 as well as long-term efforts to develop new vaccines and biologics for other conditions. With these investments, the company expects to create more than 1,500 new jobs across 11 manufacturing sites in the Americas, Europe and Asia.

08:06 EST Enveric Biosciences acquires exclusive license for novel oncology molecules - Enveric Biosciences has acquired an exclusive, perpetual license from Diverse Biotech, a biopharmaceutical company focused on developing new molecules for treating oncology and other debilitating diseases. Enveric plans to research and develop these new drugs with the goal of alleviating the side effects that cancer patients experience. Through the conjugation of cannabidiol with existing, standard-of-care drugs via Diverse Biotech's patented chemistry drug delivery platform, Enveric intends to expand its pipeline of development candidates that seek to deliver superior therapeutic outcomes for patients. As part of the agreement, Enveric will add to the company's list of target indications by obtaining five molecules, four of which are dermatology-focused and one that is pain-focused. Enveric will also gain access to Diverse Biotech's scientists and formulators to help synthesize and validate these drugs, as the company moves through pre-clinical and clinical activities.

08:04 EST GE CEO: AerCap an 'excellent partner' for GECAS - Comments taken from GE's 2021 Investor Outlook conference call.

08:02 EST Honeywell to acquire majority stake In Fiplex Communications - Honeywell has signed an agreement to acquire a majority stake in Fiplex Communications, a Miami-based company that develops in-building communications systems, including bi-directional amplifiers that provide continuous in-building radio coverage in challenging environments to improve the safety of first responders and building occupants. Fiplex's solutions will become a platform of innovation for Honeywell wireless technologies. Terms of the investment were not disclosed, and there is no change to Honeywell's financial outlook as a result of the acquisition. The acquisition is pending customary deal closing conditions.

07:55 EST Sterigenics announces expansion of Rantigny facility - Sterigenics announces the expansion of its ethylene oxide facility located in Rantigny, France to increase European sterilization capacity. The expansion increases the Rantigny facility's total sterilization throughput and diversifies its capabilities with the addition of a 32-pallet chamber. Sterigenics remains committed to addressing the growing need for sterilization in many parts of the world. The Sterigenics' Rantigny facility provides routine EO, EOStat rapid processing, cycle development and process validation and offers laboratory testing services through its co-located Nelson Labs facility. The Rantigny expansion follows Sterigenics' recent acquisition of Iotron Industries, a leading electron beam provider in North America. The acquisition further expands the company's capacity across multiple technologies throughout its global network.

07:51 EST Xoma expects cash to fund operations for multiple years - On December 31, 2020, XOMA had cash of $84.2 million compared with $56.7 million on December 31, 2019. The Company's current cash position is expected to be sufficient to fund its operations for multiple years.

07:49 EST Oncorus expects capital to be sufficient to fund requirements into late 2023 - Based upon its current operating plans and cash and cash equivalents at December 31, 2020, plus the net proceeds from the public offering of common stock in February 2021, the company expects to have sufficient capital to fund its operating expenses and capital expenditure requirements into late 2023.

07:42 EST Driven Brands expects positive same-store sales growth in 2021 - The Company is providing the following guidance for the fiscal year ending December 25, 2021: Net Store Growth: Maintenance: 80 to 90 stores; driven by roughly equal parts franchise and company-operated store growth; Car Wash: 20 to 30 stores; driven primarily by company-operated store growth; and Paint, Collision, and Glass: 60 to 70 stores; driven by franchise store growth. Positive same-store sales growth; Adjusted EBITDA as a percentage of revenue of approximately 23%, consistent with fiscal year 2020.

07:37 EST Intellia Therapeutics presents preclinical PoC for CRISPR-based in vivo editing - Intellia Therapeutics announced the presentation of preclinical data establishing proof-of-concept for non-viral genome editing of bone marrow and hematopoietic stem cells in mice. This represents the company's first demonstration of systemic in vivo genome editing in tissue outside the liver using its proprietary non-viral delivery platform. Gene editing of HSCs in vivo via a non-viral delivery system offers the potential to transform the treatment of sickle cell disease and other inherited blood disorders by overcoming the complexity and safety risks of ex vivo approaches. The company is presenting these data today at the Keystone eSymposium: Precision Engineering of the Genome, Epigenome and Transcriptome, being held virtually March 8-10, 2021. Title: "In Vivo Genome Editing of Hematopoietic Stem and Progenitor Cells": CRISPR/Cas9-based genome editing is well suited to the treatment of hereditary blood disorders, such as SCD. However, the current requirement for ex vivo manipulation of HSCs and toxic myeloablative transplantation regimens are significant barriers to widespread adoption of this approach. An in vivo gene editing strategy, in which CRISPR/Cas9 is delivered systemically as a treatment into patients, could greatly reduce the risk, cost and barriers to treatment associated with ex vivo genomic modification of HSCs. Such an approach could provide a one-time, curative treatment option for patients worldwide who are suffering from SCD. Intellia's non-viral delivery platform enables systemic administration of CRISPR/Cas9 to disease-relevant tissues. The findings being presented today demonstrate the applicability of this platform for editing cells within the bone marrow. In this proof of concept study: Lipid nanoparticles enabled transient and well-tolerated delivery of CRISPR/Cas9 to murine and human hematopoietic stem and progenitor cells in mice. Dose-dependent editing was seen in whole bone marrow as well as HSPCs, with editing levels in hematopoietic stem cells found to be durable for over one year after a single LNP administration. Editing increased upon repeat LNP administration, potentially enabling a "treat-to-target" approach. Transplantation studies showed that in vivo edited HSPCs retained their capacity to provide long term, multilineage reconstitution of bone marrow. In vivo editing in a humanized mouse model demonstrated relevance of the approach to human HSPCs.

07:32 EST Associated Banc-Corp names Andrew Harmening as CEO - Associated Banc-Corp announced that its Board of Directors has appointed Andrew Harmening as the company's president and CEO and a member of its Board of Directors, effective April 28. Harmening will also serve as president and CEO of Associated Bank, N.A. and president of Associated Trust, N.A. Harmening was most recently senior executive vice president, consumer and business banking of Huntington Bank.

07:24 EST Telespazio selects Gilat to supply enterprise connectivity in Brazil - Gilat Satellite Networks announced that Telespazio, a joint venture between Leonardo and Thales, selected Gilat to supply enterprise connectivity in Brazil for a multinational leading energy company. Gilat will provide the satellite network and thousands of VSATs to energy plants of Brazil's largest private sector energy company.

07:23 EST Lantronix announces EMG7500 edge management gateway - Lantronix announced its new EMG7500, a cost-effective, secure edge management gateway in a small form factor. Designed for use in virtually any type of remote or unmanned site, the EMG7500 is an integrated part of Lantronix's business continuity solution of interlocking hardware, software and value-added services. With the EMG7500, Lantronix is expanding its offering of REM solutions within its EMG family of Out-of-Band Management products.

07:21 EST Northern Oil and Gas announces price reduction for pending Reliance acquisition - Northern Oil and Gas announced that EQT Corporation and certain other parties have exercised their preferential rights to purchase certain properties that would have otherwise been included in Northern's recently announced Marcellus Shale acquisition from Reliance Marcellus, . These properties, primarily consisting of assets subject to a Joint Development Agreement with EQT, will therefore be excluded from Northern's pending acquisition from Reliance that is expected to close in April 2021.

07:17 EST Telesat, Satixfy partner to validate modem designs for Ligtspeed network - Telesat announced an agreement with satellite communications technology company SatixFy, giving Telesat early access to SatixFy's second-generation Sx3099 modem chip. Under the agreement, SatixFy and Telesat will demonstrate advanced modem designs for both Landing Stations and User Terminals for Telesat Lightspeed, Telesat's revolutionary Low Earth Orbit satellite network. The companies will perform a six-month requirements verification program, focused on the development and testing of evaluation boards and prototype modem units. The companies will also conduct integration work and interoperability tests with the Telesat Lightspeed satellite onboard processor.

07:15 EST First Majestic calls Mexican media articles 'inaccurate, misleading' - FIRST MAJESTIC SILVER CORP. responds to the several inaccurate and misleading Mexican media articles that have been recently published regarding the ongoing tax dispute with the Government of Mexico. In order to be transparent regarding the facts surrounding the Company's decision to file a NAFTA Request for Arbitration and for the benefit of those loyal and interested shareholders and stakeholders, the Company wishes to provide an update and a status summary of the tax dispute: In 2010 and under prior ownership, PEM acquired the San Dimas mine and assumed all obligations under a pre-existing streaming agreement with Wheaton Precious Metals dating back to 2004, whereby PEM was required to sell most of the silver production from the San Dimas mine to WPM at US$4.00 per ounce. To provide certainty of tax treatment for sales under the streaming agreement, PEM entered into an Advance Pricing Agreement, with the Mexican government in October 2012 and obtained a ruling from the Mexican tax authorities confirming the APA for the years of 2010 to 2014. The APA confirmed that taxes payable by PEM under the streaming agreement would be calculated on the basis of the actual realized revenue and not on the basis of market prices. Over the period in question PEM had a combined net earnings before taxes of approximately US$6.7 million. According to the Company's constitutional law advisors, under Mexican law, taxes may not be imposed on income not received. Contrary to the terms of the APA, which the Company has been advised remains valid in accordance with the Mexican Federal Tax Code unless and until it is nullified with finality by the Mexican Supreme Court, the Mexican government has issued tax assessments for PEM for the years 2010, 2011 and 2012 calculated on the basis of market prices and not the actual realized price. The total amount of these reassessments is approximately US$260 million of which approximately US$75 million is additional taxes. The balance of these reassessments constitutes penalties, interest and denied intercompany interest expenses. Streaming agreements like PEM's agreement with WPM are legally valid in Canada and Mexico and conform to international guidelines. At the present time, there are approximately seven active precious metal streaming agreements in Mexico's mining sector. It is unknown why SAT has singled out the PEM streaming agreement. In May 2018, First Majestic negotiated with WPM to cancel the original streaming agreement by paying WPM US$151 million and entered into a new stream agreement on revised terms which simplified the financing structure, and initiated the payment of taxes on spot pricing of silver and gold. First Majestic and WPM are completely independent public companies that deal at arm's length for the interests of their respective stakeholders/shareholders. Several unsuccessful attempts have been made by First Majestic to engage with the Mexican government authorities within the Ministry of Foreign Affairs, Ministry of Economy, Ministry of Finance and Servicio de Administracion Tributaria. Therefore, without indications from the Mexican government that a mediated resolution would be possible, and as announced last week, the Company decided on March 1st to file a NAFTA Request for Arbitration through the World Bank's International Centre for Settlement of Investment Disputes in order to formally request to bring the Mexican government to the table for an unbiased arbitration. As a further update to shareholders, and as expected, PEM recently received a notice of reassessment for the fiscal year 2013 from the SAT for the Mexican Peso amount of MXP1,866,655,000 recalculating PEM's taxable income on the basis of market prices for silver sold under the Streaming Agreement rather than actual revenue received. In accordance with the aforementioned advice by the Company's Mexican counsel, no tax is payable under these reassessments while the Company's appeals before the Mexican courts are in process and, the Company believes that its interest expenses and management fee deductions comply with applicable OECD transfer pricing principles. The Company will continue to vigorously challenge all tax reassessments through all domestic and international means available to it.

07:14 EST Garmin enters powersports market with new off-road product assortment - Garmin announced its entrance into the powersports market with a trio of solutions. With the new Tread powersport navigator with Group Ride Radio, Garmin PowerSwitch digital switch box and the BC 40 wireless camera with tube mount, riders can hop on their side-by-side, ATV, or snowmobile to navigate rolling sand dunes, forest trails in the rain, or cold snow tracks in the mountains.

07:12 EST Entercom acquires Podcorn for $14.6M upfront, earnout over next three years - Entercom announced the acquisition of Podcorn. The transaction values Podcorn at $22.5M, with an upfront cash payment of $14.6M and a performance-based earnout over the next three years. Podcorn's marketplace includes nearly 40,000 creators and has facilitated thousands of podcast ad campaigns. Podcorn creates an infrastructure for enabling direct podcaster and advertiser relationships. Agnes Kozera and David Kierzkowski will continue to lead Podcorn, joining Entercom's leadership team.

07:09 EST Townsquare Media repurchases entirety of Oaktree Capital's ownership stake - Townsquare Media (TSQ) repurchased the entirety of Oaktree Capital's (OAK) 12.6 million shares and warrants of the company at $6.40 per security, and subsequently retired those securities, comprising 1.6 million shares of Class A common stock, 2.2 million shares of Class B common stock, and 8.8 million warrants. The purchase price of $6.40 per security reflected a 39% discount to the closing price of the Class A common stock on Tuesday, March 9, and a 19% discount to the pre-announcement share price. The transaction is expected to be immediately accretive on a free cash flow per share and adjusted EPS basis in excess of 70%. The aggregate purchase price for the securities was $80.4M and was funded with cash on hand. In addition, the company will pay Oaktree a $4.5M consent fee in four installments, the first of which is due on April 1. Following the repurchase, the company has approximately 16 million securities outstanding, inclusive of common stock and warrants.

07:08 EST Newmont to acquire remaining 85.1% of GT Gold for approximately $311M - Newmont and GT Gold announced that the companies have entered into a binding agreement in which Newmont will acquire the remaining 85.1% of common shares of GT Gold not already owned by Newmont. Under the terms of the agreement, Newmont will acquire each GT Gold share at a price of C$3.25, for cash consideration of approximately $311M. The company said the Tatogga project, including the primary Saddle North deposit, has the potential to contribute significant gold and copper annual production at attractive all-in sustaining costs over a long mine life. In addition to the known deposits at Saddle North, there are further exploration opportunities throughout the land package. The acquisition of the Tatogga project adds to Newmont's existing interest in the prospective Golden Triangle through the company's 50% ownership in the Galore Creek project. The transaction is expected to close in Q2, subject to meeting normal closing conditions.

07:04 EST Eli Lilly: Bamlanivimab/etesevimab reduced COVID-19 hospitalizations, deaths - Eli Lilly and Company announced new data from the randomized, double-blind, placebo-controlled BLAZE-1 Phase 3 study, demonstrating bamlanivimab 700 mg and etesevimab 1400 mg together significantly reduced COVID-19 related hospitalizations and deaths in high-risk patients recently diagnosed with COVID-19. These results provide additional efficacy and safety data that support the use of the dose recently granted both Emergency Use Authorization by the U.S. FDA and a positive scientific opinion by the European Medicines Agency's Committee for Medicinal Products for Human Use. This new Phase 3 cohort of BLAZE-1 included 769 high-risk patients, aged 12 and older with mild to moderate COVID-19. There were four events in patients taking bamlanivimab with etesevimab and 15 events in patients taking placebo, representing an 87% risk reduction. Bamlanivimab and etesevimab together also demonstrated statistically significant improvements on key secondary endpoints. These results are consistent with those seen in other data sets from BLAZE-1: in the previous Phase 3 cohort, bamlanivimab 2800 mg with etesevimab 2800 mg reduced the risk of hospitalizations and deaths by 70 percent and in the Phase 2 cohort, bamlanivimab alone reduced the risk of hospitalizations and ER visits by approximately 70%. The viral load reductions were also consistent with what was observed in the previous Phase 3 cohort of the study.

06:55 EST Fortinet to partner AT&T in managed SASE solution - As part of its Accelerate 2021 Conference yesterday, Fortinet (FTNT) and AT&T (T) announced that AT&T is "expanding its portfolio of Managed Security Services through its alliance with Fortinet to make Secure Access Service Edge, or SASE, a reality for enterprises. AT&T SASE with Fortinet is the first, global managed SASE solution at scale that unifies software-defined wide-area network with essential network security functions of the SASE framework and 24x7 management. This powerful combination of people, processes, and technology will help enterprises to enhance security, increase network performance, and reduce complexity and costs."

06:49 EST Wex awarded multi-year contract renewal with Sourcewell - WEX has been awarded a multi-year contract renewal with Sourcewell, an agency that serves the education, nonprofit and government sectors by giving their clients access to competitively solicited cooperative contracts. The agreement allows all Sourcewell users to participate in the contract, which supplies fuel cards for municipal fleets as well as WEX Telematics premium GPS tracking. Since Sourcewell has already fulfilled the RFP process, participating agencies can access the contract without the difficulty of going through their own RFP process. Sourcewell has more than 50,000 registered users throughout North America. Participation is free for qualified government, education and nonprofit entities. .

06:47 EST Lazard reports preliminary AUM approximately $260.7B as of February 28 - The month's AUM included market appreciation of $5.6B, net inflows of $0.2B and foreign exchange depreciation of $0.3B.

06:46 EST Affimed N.V. to continue enrollment in AFM13 study after positive interim data - Affimed N.V. has decided to continue enrollment in the REDIRECT trial, which is evaluating AFM13 as a monotherapy for the treatment of patients with relapsed or refractory CD30-positive peripheral T-cell lymphoma. The decision to continue the trial followed a preplanned interim futility analysis. The interim analysis was triggered following enrollment of 20 patients in both Cohort A - greater than or equal to10% CD30 - and Cohort B - greater than1% to less than10% CD30 -. The futility analysis demonstrated that the response rate in Cohort A achieved the predefined threshold for continuation of the study. The response rate in Cohort B was sufficiently comparable to allow merging of both cohorts into a single cohort for all patients with CD30 greater than1%, per the study protocol. Evidence of anti-tumor response was observed in both cohorts with complete and partial responses. The safety analysis was consistent with previously reported data from Affimed's Phase 1 trials of AFM13, with infusion related reactions representing the main side effect. Following the introduction of mandatory premedication, IRRs were markedly reduced, resulting in fewer dose reductions and a trend towards better activity. AFM13 is also being evaluated in combination with cord-blood derived natural killer cells in CD30-positive lymphomas. Initial data from this investigator sponsored study will be presented at the American Association for Cancer Research Annual Meeting in April.

06:42 EST ChromaDex's Tru Niagen to be distributed in Walmart stores across U.S. - ChromaDex's (CDXC) flagship consumer product, NAD+ booster Tru Niagen, will be available in 3,000 Walmart (WMT) retail stores across the U.S. beginning June. ChromaDex will introduce Tru Niagen in two packaging options for Walmart customers, which will have distinct serving sizes and price points. In addition to in-store availability, these two options will be available online with same-day delivery and in-store pickup options for select locations. Niagen has received regulatory acceptance by regulatory bodies such as the FDA, Health Canada, the European Commission, and the Therapeutic Goods Administration of Australia.

06:39 EST General Electric board recommends 1-for-8 reverse stock split - In light of its significant transformation over the past several years, GE is also announcing that its Board will recommend that shareholders approve a reverse stock split at a ratio of 1-for-8 and a corresponding proportionate reduction in the number of authorized shares of common stock. The reverse stock split would decrease the number of shares outstanding to a number more typical of companies with comparable market capitalization. Whether and when to effect it would be at the discretion of GE's Board, at any time prior to the one-year anniversary of its 2021 Annual Meeting on May 4. GE will share additional information in a preliminary proxy filing, which it expects to file later this week.

06:36 EST SPX Flow initiates 9c per share quarterly dividend - SPX Flow announced that its board of directors has declared a quarterly dividend on the company's common stock of 9c per share, payable on April 14 to stockholders of record as of the close of business on March 24.

06:34 EST Hexo wins complete dismissal of federal shareholder class action - Hexo has won a complete dismissal in the federal US securities class action pending in the District Court for the Southern District of New York. Hexo and certain of its current and former officers and directors were named in shareholder class action lawsuits filed in the Southern District of New York, the New York State Supreme Court for the County of New York, and the Province of Quebec. The suits alleged that Hexo made material misstatements and omitted material information in its prior disclosures to investors regarding various issues, including but not limited to its estimated sales revenues during Q4 2019 and FY20, its supply agreement with the SQDC, and the facilities acquired from Newstrike. The Southern District of New York granted HEXO's motion to dismiss "in its entirety." The court agreed with Hexo that the plaintiffs "failed to allege actionable misstatements or omissions" under the US securities laws. The court also rejected the plaintiffs' allegations that Hexo engaged in fraudulent or reckless conduct with respect to the disclosures. Plaintiffs have a right to appeal.

06:33 EST GE to be entilted to nominate two directors to seats on AerCap's board

06:32 EST GE to receive consideration valued at more than $30B in GECAS, AerCap deal

06:32 EST General Electric announces combination of GECAS and AerCap - GE (GE) announced today an agreement to combine its GE Capital Aviation Services business, or GECAS, with AerCap Holdings N.V. (AER). GE Chairman and CEO H. Lawrence Culp, Jr. said, "Today marks GE's transformation to a more focused, simpler, and stronger industrial company. Coupled with our continuing efforts to strengthen GE's performance, operations, and culture, this deal brings GE closer to our future-delivering value for the long term and leading the energy transition, precision health, and the future of flight." Culp concluded, "This is the right time to further accelerate our transformation. This action will enable us to significantly de-risk GE and continue on our path to being a well-capitalized company. Building on our multi-year efforts to solidify our financial position, we expect to use the proceeds to further reduce debt for a total reduction of more than $70 billion since the end of 2018." After the deal closes, GE intends to use the transaction proceeds and its existing cash sources to reduce debt by approximately $30 billion, for an expected total reduction of more than $70 billion since the end of 2018. GE also expects to continue to execute significant additional debt reduction and increase earnings to reach its Industrial leverage target of less than 2.5x net debt to EBITDA over the next few years. Under the terms of the transaction agreement, which has been approved by the boards of directors of both companies, GE will receive consideration valued at more than $30 billion, including approximately $24 billion in cash, 111.5 million ordinary shares equivalent to approximately 46 percent ownership of the combined company with a market value of approximately $6 billion as of March 9, 2021, and $1 billion paid in AerCap notes and/or cash upon closing. GE will transfer $34 billion of GECAS' net assets, including its engine leasing and Milestone helicopter leasing businesses, to AerCap. Current GECAS purchase obligations will transfer to AerCap, and GECAS' more than 400 employees also will transfer to AerCap upon completion of the transaction. Under a shareholders' agreement between GE and AerCap, at closing GE will be entitled to nominate two directors to newly created seats on AerCap's board. GE will be subject to a staged lock-up agreement allowing it to dispose a portion of its stake after nine months and the entirety of its stake after 15 months. GE also will be subject to a customary standstill and other provisions. AerCap has secured $24 billion in committed financing from its banking group to support the closing of the transaction. The transaction is expected to close in 9-12 months, subject to AerCap shareholder approval, regulatory approvals, and other customary closing conditions.

06:25 EST Apple to invest over EUR1B in Germany, plans ESDC in Munich - Apple will make Munich its European Silicon Design Center, adding hundreds of new employees and a new state-of-the-art facility focused on connectivity and wireless technologies. Munich is already Apple's largest engineering hub in Europe, with close to 1,500 engineers from 40 countries working in a variety of areas including power management design, application processors, and wireless technologies, the company said in a statement. Their work is contributing to Apple's custom silicon designs with industry-leading performance, powerful features, and incredible efficiency. The expansion in Munich, together with additional investment in R&D, will exceed 1 billion euros in the next three years alone. "I couldn't be more excited for everything our Munich engineering teams will discover - from exploring the new frontiers of 5G technology, to a new generation of technologies that bring power, speed, and connectivity to the world," said Tim Cook, Apple's CEO. "Munich has been a home to Apple for four decades, and we're grateful to this community and to Germany for being a part of our journey." Reference Link

06:21 EST TSMC reports February revenue NT$106.53B, up 14.1% y/y - TSMC announced its net revenues for February 2021: On a consolidated basis, revenues for February 2021 were approximately NT$106.53B, a decrease of 15.9% from January 2021 and an increase of 14.1% from February 2020. Revenues for January through February 2021 totaled NT$233.28B, an increase of 18.4% compared to the same period in 2020.

06:08 EST Disney's Bob Iger confirms he is leaving at the end of December - Bob Iger, the longtime leader of Disney, confirmed that he will be stepping away from the company in December. Iger, who resigned as CEO last February but stayed on as executive chairman, said at the company's shareholder meeting on Tuesday: "I will leave at the end of December with a strong sense of pride and a deep sense of appreciation for the very special place Disney holds in the hearts of people all over the world." Iger added that his successor, CEO Bob Chapek, and upper management will "adhere to the same principles" that he did when leading the company.

05:59 EST Unilever to drop the word 'normal' from beauty, personal care products - Unilever, which owns brands like Dove and Sunsilk, said a study had found that the word "normal" makes most people feel excluded. The company announced that it will eliminate the word "normal" from all of its beauty and personal care brands' packaging and advertising, as part of the launch of its new Positive Beauty vision and strategy. "Positive Beauty, which sets out several progressive commitments and actions for our beauty and personal care brands, including Dove, Lifebuoy, Axe and Sunsilk, will champion a new era of beauty which is equitable and inclusive, as well as sustainable for the planet," Unilever said in a statement. Sunny Jain, President Beauty & Personal Care, said: "With one billion people using our beauty and personal care products every day, and even more seeing our advertising, our brands have the power to make a real difference to people's lives. As part of this, we are committed to tackling harmful norms and stereotypes and shaping a broader, far more inclusive definition of beauty." Reference Link

05:32 EST Imax, Broadway sign new four-theatre deal in Shanghai - Imax, Imax China and Broadway announced an agreement of four new IMAX theaters across several locations in downtown Shanghai, including One East, located in the heart of Huangpu Riverside, the first flagship property managed and operated by Brookfield Properties in Shanghai. The deal will bring four new Imax with laser systems to commercial locations in one of the country's most successful theatrical markets. It also marks an expansion of the partnership between Imax and Broadway, which currently includes Imax screens across eight of Broadway's top-performing theaters in China. With the new agreement, Imax's theatre network in China has developed to nearly 1000 total screens, including 248 in backlog.

05:18 EST Booking Group chooses IBM Cloud to meet customer demand - IBM and Booking Group announced that the online car rental company is accelerating its transformation with IBM Cloud technology and services. The company said as businesses across industries are navigating digital transformation and trying to do so as quickly as possible to remain competitive, they are looking for a hybrid multicloud model and ways to protect their data. IBM Cloud is helping Booking Group address these needs, while offering flexibility across their business processes as they adapt to a changing business environment.

05:09 EST Accenture acquires fable+, terms undisclosed - Accenture has acquired fable+, a consulting firm specializing in business agility and analytics-driven transformation. Located in Mannheim and Berlin, fable+'s team of 50 professionals have joined Accenture's talent and organization / human potential team, adding expertise focused on organizational transformation. By leveraging their proprietary cloud-based app to measure psychological safety and team performance, Fable+ can quantify culture factors that drive performance across different levels of an organization. Terms of the transaction were not disclosed.